Supports growth of Indian pharmaceutical industry
BASF will launch a production line for precious metal-based fine chemical catalysts at its manufacturing site in Mangalore, India. These catalysts are important for the efficient production of active pharmaceutical ingredients.
The new production line will begin operation in the second quarter of 2013, marking BASF’s first manufacturing operation for chemical catalysts in Asia Pacific.
‘BASF is an industry leader in developing cutting-edge catalysts and technologies for pharmaceutical and fine chemical applications,’ said Hans-Peter Neumann, svp, Process Catalysts and Technologies at BASF’s Catalysts division.
‘This expansion will allow us to cost effectively increase our manufacturing footprint and production capacity, leveraging an existing BASF facility to enhance our proximity to customers in the Asia Pacific region.’
Prasad Chandran, chairman, BASF Companies in India and Head South Asia, added: ‘India is a significant growth market for the pharmaceutical industry. As population expands, the need for new and cost-effective life-saving drugs is also on a rise. BASF has a wide range of products and solutions which find application in the pharmaceutical industry. By introducing a new production line for precious metal-based fine chemical catalysts in India, we will expand our offerings to meet the needs of local pharmaceutical producers.’
The Mangalore site is BASF’s largest manufacturing site in India and in South Asia. Operational since 1996, it currently produces performance chemicals, dispersions and paper chemicals, automotive coatings, coil coatings and construction chemicals.